In Egypt, bovine virus diarrhoea mucosal disease (BVD-MD) 
A rinderpest outbreak in 1982 involved some cattle and buffalo which had been vaccinated against the disease, and such animals were positive to the gel diffusion test for BVD MD pestivirus. Extensive immunosuppression due to BVD-MD virus was suspected, because the attenuated cell-culture vaccine against rinderpest, issued in Egypt since 1965, had not been tested for freedom from non-cytopathic BVD-MD virus.

Experimental infection of susceptible sheep with BVD MD virus resulted in symptoms of Border disease.
Innocuity of the attenuated C24V bovine pestivirus vaccine for animal tissues and the immune system of calves was confirmed.
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Occurrence of bovine virus diarrhoea-mucosal disease
Bovine virus diarrhoea-mucosal disease (BVD-MD) is believed to have been present among Egyptian cattle before 1960. Simultaneous occurrence of pneumonia and enteritis (pneumoenteritis) had been an unsolved problem in bovine calves and buffalo calves. Confirmation of BVD-MD by the serum neutralisation test on bovine sera was reported by Hafez and Frey in 1972 (12) . From the prevalence of neutralising antibodies in ovine sera, it was concluded that pestiviral infection was widespread throughout the country (10).
A cytopathic strain of pestivirus was isolated in 1970 from calves with severe pneumoenteritis and bloody diarrhoea (1, 11) . The disease tended to occur under conditions of an unhygienic water supply, poor management and bad weather.
Investigations of certain affected farms revealed that 70% of sick newborn calves had gastroenteritis, and 85.9% of serum samples contained neutralising antibody to BVD-MD virus (13) .
Properties of viral isolates and antigenic relationships
By using reference sera it was shown that many of the virus strains isolated were BVD MD virus, and one strain (the "Iman" strain) was examined in detail.
The titre of the Iman strain in cell culture was measured as ranging from 10 46 to 10 5.5 CCID50/O.1 ml by the infectivity method and 10 6 3 PFU/ml by the plaque technique.
A cytopathic effect was observed in bovine kidney (BK) and bovine testis cell cultures. Physical and chemical properties of the second plaque-purified isolate were studied. The cytopathic effect of the Iman strain on BK cells was the same as that of other BVD-MD virus strains, with cytoplasmic vacuolation and chromatin fragmentation.
Comparison of reactions of the Iman strain and reference sera against various pestivirus isolates revealed a general relationship, but with certain antigenic differences. The Iman strain was closely related to other BVD-MD virus isolates from different localities in Egypt, again with some antigenic differences.
Results of two investigations in Egypt
Investigations carried out on two farms (which were representative of Egyptian conditions) into the role of BVD-MD virus and colostral antibodies in calf diseases gave the following results (1) .
Role of the virus in pneumonia
and enteritis BVD-MD virus was responsible for 58.5% of cases of pneumoenteritis in bovine calves, but only 9.3% of cases in buffalo calves. Subclinical infection was detected in some calves during observation of colostral antibodies between birth and three months. BVD-MD virus infection, whether clinical or subclinical, occurred in 39% of bovine calves and 18.7% of buffalo calves.
Studies on colostral antibodies
The colostral transfer of antibodies provided calves with an antibody titre equal to, or greater than that of their dam. During the first three months of age, there was an abrupt fall in titre (to 1:16) in 55.5% of calves, a gradual fall (to 1:64) in 11% and a much slower fall (to 1:256) in 33.3% of calves.
Clinical observations and the role of colostral antibodies
The signs of illness in calves were depression, complete anorexia, severe diarrhoea, salivation, conjunctivitis, recumbency. Congestion and ulceration of the oral mucosa and lameness were also observed.
It was concluded that calves which do not possess antibody may contract the disease. Antibody titres of 1:4, 1:16 and 1:64 provided no protection against subsequent reinfection, as shown by rises in titre after reinfection. Infection with BVD MD virus was rarer in buffalo than in bovines, and antibody titres were lower than in bovines (1:4 or 1:16). Failure of calves to acquire colostral antibodies was due to low titres (e.g. 1:16) in the dam or to rapid loss after acquisition. Calves with an antibody titre of 1:16 were susceptible to infection.
Conclusions
Conclusions drawn from these studies are as follows: BVD-MD virus infection, verified by isolating the virus, is not always followed by antibody formation -calves can acquire BVD-MD virus infection even if their antibody titre is 1:256 -titres rise by four times or more after infection colostral antibody may persist in calves until three months of age.
Interesting cases and immune tolerance
One calf died from pneumoenteritis at seven days. Antibody titres of 1:1024 were observed in serum from the calf and its dam. The carcass was severely dehydrated and there was congestion, with haemorrhages, throughout the digestive tract. This calf may have acquired infection within the uterus before it was immunologically competent. Antibodies were present, but they were not transferred to the calf at the right time. BVD-MD virus was isolated from a similar case. Several other calves on the farms studied had died within a few days of birth.
Immune tolerance was suspected in a bovine calf from which the virus was isolated, and which developed profuse salivation, diarrhoea and cough at thirteen days. Tests on paired serum samples obtained from the calf and its dam were negative for antibodies.
Since buffalo calves possess only low titres of BVD-MD virus antibodies and the antibody titres show little rise in diseased calves, immune tolerance might be a problem in buffalo.
Mixed viral infections
Newborn animals are susceptible to other viral infections. A study of 596 bovine calves and 345 buffalo calves with pneumoenteritis showed the major cause to be single or mixed infection with infectious bovine rhinotracheitis (IBR), parainfluenza 3 (PI-3) and BVD-MD viruses (6) . In bovine calves, disease syndromes occurred most often during the first month after birth (38.5% of cases), less frequently during the second month (36.6% of cases), rarely during the third month (14.5%) and least frequently after the third month (10.3%). The respective percentages for buffalo calves were 35.5%, 25%, 16.5% and 13%. Among cases of pneumoenteritis in bovine calves, serological testing indicated the presence of BVD-MD virus in 56%, IBR virus in 8% and PI-3 virus in 64%. The corresponding percentages in buffalo calves were 10%, 14% and 42% (8) .
Incidence
Serum samples from 500 cattle representative of all parts of Egypt were found positive for BVD-MD virus in 33.4% of tests, for IBR virus in 21.5% and PI-3 virus in 92% (9) .
Some problems of the animal industry
The animal industry was concerned about unthriftiness in cattle and high mortality rates among bovine and buffalo calves, sometimes reaching 50-60% (3).
One study of a farm experiencing unthriftiness and severe pneumoenteritis indicated involvement of BVD-MD, IBR and PI-3 viruses. BVD-MD virus was isolated from some calves which had no BVD-MD virus antibody (2).
Some of the cattle and buffalo affected by the rinderpest outbreak of 1982 had been vaccinated against rinderpest, and immunosuppression due to BVD-MD virus was suspected, because the attenuated rinderpest vaccine produced in BK cell cultures had not been tested for freedom from non-cytopathic BVD-MD virus since it was first issued in 1965 (5). Because of this, steps were taken to test the rinderpest vaccine and investigate the occurrence of BVD-MD in Egypt.
A non-cytopathic strain of BVD-MD virus was isolated in 1987 from three kidneys obtained from the Cairo abattoir during three consecutive weeks (7) . This indicated the prevalence of the non-cytopathic BVD-MD virus, which could pollute tissue cultures used for vaccine preparation.
Rinderpest continued to affect animals previously vaccinated, particularly fattening calves, during successive years, which indicated that the problem of immuno suppression had not been overcome.
It was interesting to observe that the annual mortality rate in newborn calves fell from between 50% and 60% to zero with the introduction of an inactivated, combined respiratory vaccine prepared from BVD-MD virus, IBR virus, PI-3 virus, adenovirus and reovirus. This indicates that the immune response was unimpaired at an early age. Because mortality remained constant in unvaccinated fattening animals, the specific and non-specific immune mechanisms of calves were evidently compromised. Evidence of immunosuppression due to BVD-MD virus was obtained on a buffalo farm which used the combined vaccine. Twenty percent failed to respond to vaccination and 40% developed only a weak antibody response (4).
A national programme has been proposed to control immunosuppression and establish a population of immunocompetent animals. An associated programme to control other diseases has also been proposed, because certain viruses are able to infect cattle immunotolerant to BVD-MD virus, inducing some severe infections with high mortality.
Experimental infection of sheep
When susceptible lambs were inoculated with a virulent strain of BVD-MD virus, they became infected and developed symptoms similar to those of Border disease (congenital hypomyelinogenesis). Histopathological lesions were similar to those of BVD-MD, comprising dehydration, haemorrhages and lymph node depletion. Calves and lambs became infected on contact with the infected lambs. It was concluded that pestiviral infections among the cattle and sheep of Egypt should be brought under control (14) .
Evaluation of vaccine in calves
Experiments with immunocompetent, susceptible calves confirmed the safety and efficacy of the attenuated C 24 V pestivirus vaccine. It had no adverse effect on body tissues or the immune system, and immunity lasted for sixteen months (15) . Se confirmó la inocuidad de la vacuna atenuada de pestivirus bovino C24V para los tejidos animales y el sistema inmunitario de los terneros.
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